Curcumin reduces the expression of interleukin 1β and the production of interleukin 6 and tumor necrosis factor alpha by M1 macrophages from patients with Behcet's disease

References

• Gul A. Pathogenesis of Behcet's disease: autoinflammatory features and beyond. Semin Immunopathol. 2015;37:413–418.
   PubMed Web of Science ®Google Scholar
• Mazzoccoli G, Matarangolo A, Rubino R, et al. Behcet syndrome: from pathogenesis to novel therapies. Clin Exp Med. 2016;16:1–12.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I. Behçet's uveitis. Middle East Afr J Ophthalmol. 2009;16:219–224.
   PubMedGoogle Scholar
• Zhou ZY, Chen SL, Shen N, Lu Y. Cytokines and Behcet's disease. Autoimmun Rev. 2012;11:699–704.
   PubMed Web of Science ®Google Scholar
• Davies LC, Jenkins SJ, Allen JE, et al. Tissue-resident macrophages. Nat Immunol. 2013;14:986–995.
   PubMed Web of Science ®Google Scholar
• Laria A, Lurati A, Marrazza M, et al. The macrophages in rheumatic diseases. J Inflamm Res. 2016;9:1–11.
   PubMed Web of Science ®Google Scholar
• Taylor J, Glenny AM, Walsh T, et al. Interventions for the management of oral ulcers in Behcet's disease. Cochrane Database Syst Rev. 2014;9:CD011018.
   Google Scholar
• Kaklamani VG, Kaklamanis PG. Treatment of Behcet's disease–an update. Semin Arthritis Rheum. 2001;30:299–312.
   PubMed Web of Science ®Google Scholar
• Gautam SC, Gao X, Dulchavsky S. Immunomodulation by curcumin. Adv Exp Med Biol. 2007;595:321–341.
   PubMed Web of Science ®Google Scholar
• Perrone D, F, Ardito G, Giannatempo M, et al. Biological and therapeutic activities, and anticancer properties of curcumin. Exp Ther Med. 2015;10:1615–1623.
   PubMed Web of Science ®Google Scholar
• Alok A, Singh ID, Singh S, et al. Curcumin -- pharmacological actions and its role in oral submucous fibrosis: a review. J Clin Diagn Res. 2015;9:1–3.
   Google Scholar
• Aggarwal BB, Gupta SC, Sung B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol. 2013;169:1672–1692.
   PubMed Web of Science ®Google Scholar
• Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol. 1995;49:1551–1556.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang T, Wang X, et al. Curcumin Modulates macrophage polarization through the inhibition of the toll-like receptor 4 expression and its signaling pathways. Cell Physiol Biochem. 2015;36:631–641.
   PubMed Web of Science ®Google Scholar
• Singh S, Aggarwal BB. Activation of transcription factor NF-kappa. J Biol Chem. 1995;270:24995–25000.
   PubMed Web of Science ®Google Scholar
• Xu YX, Pindolia KR, Janakiraman N, et al. Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol. 1997;11:49–62.
   PubMedGoogle Scholar
• Gao S, Zhou J, Liu N, et al. Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13. J Mol Cell Cardiol. 2015;85:131–139.
   PubMed Web of Science ®Google Scholar
• Bright JJ. Curcumin and autoimmune disease. Adv Exp Med Biol. 2007;595:425–451.
   PubMed Web of Science ®Google Scholar
• Funk JL, Oyarzo JN, Frye JB, et al. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod. 2006;69:351–355.
   PubMed Web of Science ®Google Scholar
• Deodhar SD, Sethi R, Srimal RC. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res. 1980;71:632–634.
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Priem F, Mobasheri A. Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management. Springerplus. 2013;2:56.
   PubMedGoogle Scholar
• Handono K, Pratama MZ, Endharti AT, et al. Treatment of low doses curcumin could modulate Th17/Treg balance specifically on CD4+ T cell cultures of systemic lupus erythematosus patients. Cent Eur J Immunol. 2015;4:461–469.
   Google Scholar
• International Criteria for Behcet's Disease (ICBD). Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s disease. Lancet. 1990;335:1078–1080.
   PubMed Web of Science ®Google Scholar
• Rezaiemanesh A, Mahmoudi M, Amirzargar AA, et al. Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23. Mod Rheumatol. 2017;27:862–867.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101–1108.
   PubMed Web of Science ®Google Scholar
• Alpsoy E. Behcet's disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. 2016;43:620–632.
   PubMed Web of Science ®Google Scholar
• Direskeneli H. Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford). 2006;45:1461–1465.
   PubMed Web of Science ®Google Scholar
• Park UC, Kim TW, Yu HG. Immunopathogenesis of ocular Behcet's disease. J Immunol Res. 2014;2014:653539.
   PubMedGoogle Scholar
• Saleh Z, Arayssi T. Update on the therapy of Behcet disease. Ther Adv Chronic Dis. 2014;5:112–134.
   PubMedGoogle Scholar
• Nagpal M, Sood S. Role of curcumin in systemic and oral health: an overview. J Nat Sc Biol Med. 2013;4:3–7.
   PubMedGoogle Scholar
• Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41:40–59.
   PubMed Web of Science ®Google Scholar
• Akdeniz N, Esrefoglu M, Keles MS, et al. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease. Ann Acad Med Singapore. 2004;33:596–599.
   PubMed Web of Science ®Google Scholar
• Bardak Y, Aridogan BC. The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behcet's disease with ocular involvement. Ocul Immunol Inflamm. 2004;12:53–58.
   PubMed Web of Science ®Google Scholar
• Mege JL, Dilsen N, Sanguedolce V, et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993;20:1544–1549.
   PubMed Web of Science ®Google Scholar
• Tourkina E, Gooz P, Oates JC, et al. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol. 2004;31:28–35.
   PubMed Web of Science ®Google Scholar
• Bosman B. Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol Physiol. 1994;7:324–334.
   Google Scholar
• Deshmukh RA, Bagewadi AS. Comparison of effectiveness of curcumin with triamcinolone acetonide in the gel form in treatment of minor recurrent aphthous stomatitis: a randomized clinical trial. Int J Pharma Investig. 2014;4:138–141.
   PubMedGoogle Scholar
• Lim YS, Kwon SK, Park JH, et al. Enhanced mucosal healing with curcumin in animal oral ulcer model. Laryngoscope. 2016;126:E68–E73.
   PubMed Web of Science ®Google Scholar